Evidence map›Paper›PMID 36873553›Full record

ArticleHeliyon2023

The effect of different

Gewa Saad, Maya Azrad, Meral Aias, Tamar Leshem, Zohar Hamo, Layan Abu Rahmoun, Avi Peretz

Abstract read
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Platelets promote human macrophages-mediated macropinocytosis ofFrontiers in cellular and infection microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gewa SaadAzrieli Faculty of Medicine, Bar Ilan University, Safed, 1311502, Israel.
Maya AzradClinical Microbiology Laboratory, Tzafon Medical Center, Poriya, Tiberias 1528001, Israel.
Meral AiasAzrieli Faculty of Medicine, Bar Ilan University, Safed, 1311502, Israel.
Tamar LeshemClinical Microbiology Laboratory, Tzafon Medical Center, Poriya, Tiberias 1528001, Israel.
Zohar HamoAzrieli Faculty of Medicine, Bar Ilan University, Safed, 1311502, Israel.
Layan Abu RahmounAzrieli Faculty of Medicine, Bar Ilan University, Safed, 1311502, Israel.
Avi PeretzAzrieli Faculty of Medicine, Bar Ilan University, Safed, 1311502, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Methods: RAW 264.7 macrophages were exposed to six different strains of Results: Strains ST37 and ST42 affected macrophages' vitality the most. Toxins A and B led to a significant reduction in macrophages' vitality at most time points. In addition, starting at 30-min post-exposure to 5 ng/μl of both toxins led to significant differences in macrophage viability versus at lower concentrations. Furthermore, cytokine secretion levels, including IL-12, IL-6 and TNF-α, increased dramatically when macrophages were exposed to strains ST42 or ST104. Finally, gene expression surveys point to increases in IL-12 gene expression in response to both ST42 and ST104. Conclusions:

Indexed as

C. difficileCytokine levelsMacrophages activityMLSTStrainsToxins levels

Identifiers

PMID36873553
PMCPMC9982624

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.